Surly some sort of announcement to shareholders on the progress of the suspension instead of the same old Locke deal getting blown out to another month seems that’s all we hear .
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%